Response to second HEFCE consultation on the Research Excellence Framework
16 December 2009
Response to second HEFCE consultation on the Research Excellence Framework
Related case studies
Reducing blood transfusions to lower patient risk, reduce costs and save lives
More than half a million people in the UK receive a blood transfusion each year and demand is increasing. Our ageing population, and a stringent donor selection process, mean the supply of blood is limited. 40% fewer new donors came forward last year compared with a decade ago. Recognising these challenges, researchers at the University of Edinburgh have shown the benefits of reducing the use of blood transfusions in intensive care and surgery.
Read more >
University of Cambridge - Delivering new treatments for multiple sclerosis
A multiple sclerosis treatment used by more than 24,000 people worldwide and judged the most cost-effective treatment for MS in 2014 was developed at the University of Cambridge.
Read more >
-
Hamir Patel
hamir.patel@russellgroup.ac.uk
020 3816 1316
-
Stephanie Smith
020 3816 1310